Navigation Links
Mesothelioma Litigation Attorney, Christopher Placitella to Lead Expert Panel on Mass Tort Litigation in New Jersey
Date:3/1/2011

RED BANK, N.J., March 1, 2011 /PRNewswire/ -- The New Jersey Institute for Continuing Legal Education has announced their 'Evolving World of Handling Mass Tort Claims' conference, to be held June 2, 2011. This mass tort litigation event will feature state and local experts in the field of mass tort litigation led by attorneys Christopher Placitella, partner at the law firm of Cohen, Placitella & Roth and Steven A. Karg, attorney at the law firm of Norris McLaughlin & Marcus, PA. There will also be presentations by Hon. Carole E. Higbee, P.J. Cv., Hon. Brian R. Martinotti, JSC., Hon. Jessica R. Mayer JSC. For the public there is a $199 tuition charge which includes dinner and seminar materials. The event is free and open to law students and full time judges.

Currently, NJ recognizes several mass torts that are handled by the Special Mass Tort Section. Those 16 mass torts include Accutane, Asbestos, Bextra/Celebrex, Bristol-Meyers-Squib, Ciba Geigy, Digitek, Fosamax, Gadolinium, HRT, Levaquin, Mahwah Toxic Dump Site, NuvaRing, Ortho Evra, Risperdal/Seroquel/Zyprexa, Vioxx, and Zometa/Aredia. In addition there are 6 centrally managed cases, Pelvic Mesh; Reglan; Stryker Implant; Pompton Lakes; Prudentional Tort; and Zelnorm. Four Superior Court Judges have been assigned by the Chief Justice to exclusively manage these cases.  

Christopher Placitella, widely regarded as one of the country's leading legal authorities on mass torts, mesothelioma litigation, asbestos related diseases, and toxic torts, will open the conference as well as present "Developments in Asbestos Litigation," an expert seminar on learning what it takes to represent a mesothelioma and asbestos litigation case, and take it to trial.

According to Placitella, "This is the 5th year in a row that we have run this seminar. Every year the attendance increases. Our presenters include some of the most respected Judges and attorneys in the country involved in Mass Tort Litigation."

The "Evolving World of Handling Mass Tort Claims" event will be held at the New Jersey Law Center at 1 Edwin Place in New Brunswick from 5:00 p.m.-8:30 p.m.  

This program has been approved by the Board on Continuing Legal Education of the Supreme Court of New Jersey for 3.7 hours of total CLE credit. Of these, 3.7 qualify as hours of credit toward certification in civil trial law.

www.cprlaw.com


'/>"/>
SOURCE Cohen, Placitella & Roth, P.C.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. International Symposium on Malignant Mesothelioma 2008
2. Caraco Pharmaceutical Laboratories, Ltd. Closes Asset Purchase Agreement with Forest Laboratories, Inc. to Settle Lexapro(R) (escitalopram oxalate) ANDA Patent Litigation
3. GlaxoSmithKline and U.S. Patent and Trademark Office File a Motion to Dismiss Litigation Over Final Regulations
4. Shire and Sandoz Settle all Pending Litigation Concerning ADDERALL XR(R)
5. Volcano Corporation Announces Litigation Status
6. LifeVantage Announces Settlement of Zrii Litigation
7. Simmons Firms Partner Trent Miracle Chosen to Help Lead National Litigation Against Bayer
8. Patheon and JLL Partners Announce Litigation Settlement
9. Shire and Teva Settle Litigation Concerning Supply of ADDERALL XR Authorized Generic
10. Leading Denture Cream Litigation Firm Welcomes GSK Announcement of Removal of Zinc From Its Denture Creams
11. Caliper Settles Outstanding Litigation with Shimadzu
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... , March 27, 2017 BioLineRx ... and immunology, announced today that AGI-134, an immunotherapy for the ... of Agalimmune Ltd., will be featured at the upcoming ... Washington, DC to be held on ... ...
(Date:3/27/2017)... March 27, 2017  BERG, a biopharmaceutical ... biological research approach, today announced that the ... discovery of new data using a cold-induced ... fat metabolism. Joslin Diabetes Center led the ... platform for analysis of samples.  The findings ...
(Date:3/27/2017)... and BOSTON , ... a leading global pharmaceutical company and Paratek Pharmaceuticals, ... the development and commercialization of innovative therapies based ... 3 trials of sarecycline for the treatment of ... primary efficacy endpoints. Sarecycline is a once-daily, oral, ...
Breaking Medicine Technology:
(Date:3/27/2017)... ... March 27, 2017 , ... Buzzies parent company, The TouchPoint Solution’s ... the Runway Foundation and UBS’ Project Entrepreneur. Mayo will present her pitch about the ... , Project Entrepreneur’s second annual venture competition ignites bold ideas by providing women access ...
(Date:3/27/2017)... , ... March 27, 2017 , ... The Case Management ... of Directors on June 30, 2017. CMSA’s membership has elected their upcoming President-Elect, ... our current Military Advisory position, a new VA Advisory position has also been added ...
(Date:3/27/2017)... Birmingham, Clarkston, and Lake Orion, Michigan (PRWEB) , ... ... ... can affect weight loss results. The comprehensive weight management program at Women’s ... begins with an initial evaluation and physical exam. The specialists at ...
(Date:3/27/2017)... ... March 27, 2017 , ... Kwalu, a leading provider of ... row; they are the recipient of the prestigious “Best Overall Design Strategy in ... at Design Connections 2017. Top A&D professionals from leading firms, furniture manufacturers and ...
(Date:3/27/2017)... ... March 27, 2017 , ... According to the American Cancer Society , ... more than 95%. Once the cancer spreads to other organs, bones, or lymph nodes, ... how to avoid this latter group, tune in to Lifestyle Magazine on ...
Breaking Medicine News(10 mins):